AR024820A1 - Composicion para la prevencion de fatiga muscular y adaptacion del musculo esqueletal a un ejercicio extenuante. - Google Patents

Composicion para la prevencion de fatiga muscular y adaptacion del musculo esqueletal a un ejercicio extenuante.

Info

Publication number
AR024820A1
AR024820A1 ARP000103777A ARP000103777A AR024820A1 AR 024820 A1 AR024820 A1 AR 024820A1 AR P000103777 A ARP000103777 A AR P000103777A AR P000103777 A ARP000103777 A AR P000103777A AR 024820 A1 AR024820 A1 AR 024820A1
Authority
AR
Argentina
Prior art keywords
composition
prevention
muscle
adaptation
fatigue
Prior art date
Application number
ARP000103777A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of AR024820A1 publication Critical patent/AR024820A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se describe una composicion que es apropiada para la prevencion y/o tratamiento de deficiencias energéticas musculares y estados de astenia, conel fin de mejorar el rendimiento de estados de fatiga cardíaca, pudiendo tener dicha composicion la formade un suplemento para dietas, soportes dietéticos, oun medicamento, que comprende como ingredientes caracterizantes, una combinacion de L-carnitina y/o por lo menos una L-carnitina de alcanoilo y fosfato decreatinol.
ARP000103777A 1999-07-23 2000-07-21 Composicion para la prevencion de fatiga muscular y adaptacion del musculo esqueletal a un ejercicio extenuante. AR024820A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000467A IT1306173B1 (it) 1999-07-23 1999-07-23 Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.

Publications (1)

Publication Number Publication Date
AR024820A1 true AR024820A1 (es) 2002-10-23

Family

ID=11406897

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103777A AR024820A1 (es) 1999-07-23 2000-07-21 Composicion para la prevencion de fatiga muscular y adaptacion del musculo esqueletal a un ejercicio extenuante.

Country Status (21)

Country Link
US (1) US6602512B1 (es)
EP (1) EP1196046B1 (es)
AR (1) AR024820A1 (es)
AT (1) ATE263496T1 (es)
AU (1) AU778647B2 (es)
CA (1) CA2377128C (es)
CZ (1) CZ20023A3 (es)
DE (1) DE60009704T2 (es)
DK (1) DK1196046T3 (es)
ES (1) ES2216931T3 (es)
HU (1) HU228838B1 (es)
IL (1) IL147408A0 (es)
IT (1) IT1306173B1 (es)
MX (1) MXPA02000780A (es)
NO (1) NO20020337L (es)
PL (1) PL204743B1 (es)
PT (1) PT1196046E (es)
SK (1) SK942002A3 (es)
TN (1) TNSN00161A1 (es)
TR (1) TR200200179T2 (es)
WO (1) WO2001006873A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
DE10160485A1 (de) * 2001-12-08 2003-10-02 Degussa Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) * 2004-03-01 2005-09-22 Degussa Ag Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
US20060083793A1 (en) * 2004-09-29 2006-04-20 Gardiner Paul T Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
EP1904070A4 (en) * 2005-07-07 2009-09-02 H3 Formulations Ltd NUTRITIONAL SUPPLEMENT FOR IMPROVING SKELETAL MUSHROOMS, REDUCING MUSCLE PROTEIN DEGRADATION, DOWNGRADING MUSCLE CATABOLISM PATHS, AND REDUCING CATABOLISM OF MUSCLE CELLS
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
WO2008025115A1 (en) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US7368441B2 (en) * 2006-08-30 2008-05-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
EP2061473A4 (en) * 2006-08-30 2009-11-11 Aplodan Formulations Ltd INCREASE IN THE AVAILABILITY OF ATP BY INHIBITING CREATINE KINASE LEAKAGE (CK) RESULTING FROM INTENSE EXERCISE
US7375097B2 (en) * 2006-08-30 2008-05-20 Aplodan Formulations Ltd. Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US20110105786A1 (en) * 2009-11-02 2011-05-05 Tianjin Tiancheng Pharmaceutical Co., Ltd. Creatinol o-phosphate and synthesis method thereof
WO2012079058A2 (en) 2010-12-10 2012-06-14 Broady Health Sciences, Llc Use of jasmonate to treat bladder dysfunction
BR112016028654A2 (pt) * 2014-06-12 2018-07-10 Lonza Ag método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
US10888571B2 (en) 2015-12-18 2021-01-12 Lonza Consumer Health Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP2002510604A (ja) 1998-04-02 2002-04-09 アビセナ グループ， インク． クレアチン化合物及び第二物質の組み合わせを含む組成
ES2146555B1 (es) 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

Also Published As

Publication number Publication date
WO2001006873A1 (en) 2001-02-01
HUP0202298A3 (en) 2005-07-28
EP1196046B1 (en) 2004-04-07
PL204743B1 (pl) 2010-02-26
ATE263496T1 (de) 2004-04-15
AU778647B2 (en) 2004-12-16
TR200200179T2 (tr) 2002-06-21
EP1196046A1 (en) 2002-04-17
ITRM990467A0 (it) 1999-07-23
AU6468700A (en) 2001-02-13
MXPA02000780A (es) 2002-08-20
DE60009704T2 (de) 2005-04-14
DE60009704D1 (de) 2004-05-13
HU228838B1 (en) 2013-06-28
IL147408A0 (en) 2002-08-14
SK942002A3 (en) 2002-05-09
PL352683A1 (en) 2003-09-08
DK1196046T3 (da) 2004-08-02
PT1196046E (pt) 2004-08-31
CZ20023A3 (cs) 2002-06-12
ES2216931T3 (es) 2004-11-01
NO20020337L (no) 2002-03-22
TNSN00161A1 (fr) 2005-11-10
ITRM990467A1 (it) 2001-01-23
NO20020337D0 (no) 2002-01-22
CA2377128A1 (en) 2001-02-01
US6602512B1 (en) 2003-08-05
HUP0202298A2 (en) 2002-10-28
CA2377128C (en) 2009-09-22
IT1306173B1 (it) 2001-05-30

Similar Documents

Publication Publication Date Title
AR024820A1 (es) Composicion para la prevencion de fatiga muscular y adaptacion del musculo esqueletal a un ejercicio extenuante.
Naderi et al. Co-ingestion of nutritional ergogenic aids and high-intensity exercise performance
Sandhu et al. Renal failure and exercise-induced rhabdomyolysis in patients taking performance-enhancing compounds
AR018924A1 (es) Composicion para la prevencion y/o tratamiento de osteoporosis y alteraciones debidas al sindrome de menopausia
AR022076A1 (es) Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
AR045569A1 (es) Composiciones alimenticias que tienen un efecto de saciedad aumetado
SK12398A3 (en) Two-stage preparation
AR023391A1 (es) Composicion que contiene carnitina e inositol fosfato, util como suplemento dietario o droga
BR9909712A (pt) Composição compreendendo l-carnitina ou um alcanoil-l-carnitina e nadh e/ou madph
AR021172A1 (es) Composicion antiprolifica, antioxidante, que comprende una carnitina y un carotenoide
CA2381339A1 (en) Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
Johnson et al. Effects of dietary aluminum and niacin on chick tibiae
CN104855977A (zh) 一种防治矽肺的营养保健食品及制备方法
CN109259222A (zh) 一种减肥冲剂
TWM645242U (zh) 天然香草複方精油貼片
Stellingwerff Nutrition recommendations for altitude training
CL2023002451A1 (es) Composiciones y métodos que usan una combinación de oleuropeína y vitamina b6
CN112471514B (zh) 一种促进运动后体能恢复的食品组合物
CL2023002452A1 (es) Composiciones y métodos que usan una combinación de oleuropeína y magnesio
Foreman Sarcopenia: The osteoporosis of the 21st century
Protection et al. Inwellness Pack A Supplement Trio to Achieve Optimal Nutrition
Arazi et al. The effects of dietary creatine ethyl ester supplementation and resistance training on the body composition and muscular strength in underweight non-athlete males
CN1459289A (zh) 一种保健食品
Dudgeon et al. Seven Days Of Mushroom Blend Supplementation Improve Measures Of Aerobic And Anaerobic Performance: 3268 Board# 173 June 2 2: 00 PM-3: 30 PM
Thomas et al. Increased Time to Fatigue Following Twenty-Eight Days of Mushroom Blend Supplementation: 3269 Board# 174 June 2 2: 00 PM-3: 30 PM